Form 4: Quest Diagnostics SVP Sells Shares for Tax Obligations

Quest Diagnostics' SVP of Clinical Solutions, Karthik Kuppusamy, reported a sale of 205 common shares to cover tax liabilities from restricted stock unit vesting.

Summary

• Karthik Kuppusamy, SVP, Clinical Solutions at Quest Diagnostics Inc. (DGX), reported a change in beneficial ownership.
• On March 2, 2026, 205 shares of common stock were disposed of at a price of $204.86 per share.
• This disposition was a 'sell-to-cover' transaction, specifically to satisfy tax obligations arising from the vesting of previously granted restricted share units.
• Following the transaction, Mr. Kuppusamy directly owns 9,869 shares, indirectly owns 358 shares via a trust, and 1,658 shares indirectly through the company's 401(k) plan.
• The direct ownership amount includes exempt purchases made under the company's stock purchase plan since the date of the reporting person's last Form 4 filing.
• The 401(k) shares were acquired on a periodic basis by the trustee of the Company's tax-qualified Profit Sharing (401(k)) Plan.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as the sale of shares was for tax purposes related to RSU vesting, a common and non-discretionary transaction for executives.

Future Outlook

NA

Industry Context

StockSavvy.ai notes that 'sell-to-cover' transactions are standard practice for executives receiving equity compensation, particularly restricted stock units (RSUs). They are generally not indicative of management's sentiment about the company's future prospects, unlike open market sales, and are considered a routine compliance filing.

Key Dates

Recommendation

This Form 4 reports a standard 'sell-to-cover' transaction by an executive to meet tax obligations upon the vesting of restricted stock units. Such transactions are common and generally not indicative of the executive's sentiment regarding the company's future performance or a change in the company's fundamentals. Therefore, it does not provide a basis for altering an existing investment thesis, leading to a 'hold' recommendation.

Keywords

Quest Diagnostics, DGX, Karthik Kuppusamy, SVP Clinical Solutions, Form 4, Insider Transaction, Stock Sale, Restricted Stock Units, Tax Obligations, Beneficial Ownership